laboratory animals
histology
doxorubicin-induced
cardiotoxicity
monitoring
treatment
animals
method
measure
ECG
values
mice
telemetry
model
investigated
effect
chronic
doxorubicin
administration
ECG
BALB/c mice
efficacy
ICRF-187
protective agent
ST
week
weekly
doses
doxorubicin
weeks
observation
ECG
control animals
study
sacrifice
hearts
doxorubicin-treated animals
enlarged
atria
hypertrophic
schedule
toxicity
investigate
protective agents
protection
ICRF-187
dose schedule
toxicity
weekly
doses
doxorubicin
weeks
observation
schedule
animals
hearts
normal
sacrifice
ICRF-187
i.p.
doxorubicin
protection
data
histology
results
model
sensitive
monitoring
development
cardiotoxicity
time
findings
model
testing
protectors
doxorubicin-induced
cardiotoxicity
protection
ICRF-187
